Prothena
PRTA
#6872
Rank
$0.59 B
Marketcap
$11.07
Share price
-0.81%
Change (1 day)
-21.21%
Change (1 year)

Earnings for Prothena (PRTA)

Earnings in 2025 (TTM): -$0.23 Billion USD

According to Prothena's latest financial reports the company's current earnings are $11.78 Million USD. In 2024 the company made an earning of -$0.16 Billion USD, an increase over its 2023 earnings that were of -$0.2 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prothena from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$0.23 Billion43.79%
2024 -$0.16 Billion-19.09%
2023 -$0.2 Billion45.21%
2022 -$0.14 Billion-282.78%
2021 $71.97 M-163.84%
2020 -$0.12 Billion33.94%
2019 -$84.17 Million-44.78%
2018 -$0.16 Billion-0.97%
2017 -$0.16 Billion-3.33%
2016 -$0.16 Billion99.17%
2015 -$79.94 Million1102.24%
2014 -$6.65 Million-83.55%
2013 -$40.43 Million-2.37%
2012 -$41.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alkermes
ALKS
$0.40 B-282.50%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Alnylam Pharmaceuticals
ALNY
$0.13 B-158.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amarin Corporation
AMRN
-$85.11 Million-61.71%๐Ÿ‡ฎ๐Ÿ‡ช Ireland